{"id":"placebo-matching-drf","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3545394","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo matching DRF (Dose Range Finding) refers to an inert control formulation used in Phase 3 trials to maintain blinding while evaluating different doses of an active therapeutic agent. The placebo is formulated to be indistinguishable from the active drug in terms of appearance, taste, texture, and administration route, ensuring that neither patients nor clinicians can identify treatment assignment.","oneSentence":"This is a placebo formulation designed to match the appearance and administration characteristics of an active investigational drug in a blinded clinical trial.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:51:30.738Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07483632","phase":"PHASE3","title":"A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)","status":"NOT_YET_RECRUITING","sponsor":"Biogen","startDate":"2026-11-16","conditions":"Relapsing Forms of Multiple Sclerosis","enrollment":185},{"nctId":"NCT05798520","phase":"PHASE2","title":"A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)","status":"COMPLETED","sponsor":"Biogen","startDate":"2023-07-25","conditions":"Relapsing Forms of Multiple Sclerosis","enrollment":127},{"nctId":"NCT07275515","phase":"PHASE2","title":"DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE BLIND RANDOMIZED CLINICAL TRIAL","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-02-01","conditions":"Stroke","enrollment":192}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo matching DRF","genericName":"Placebo matching DRF","companyName":"Biogen","companyId":"biogen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}